Status:
COMPLETED
Minimizing the Effects of COVID-19 Hospitalization With the COVID Rehabilitation Program for the Elderly
Lead Sponsor:
Université de Sherbrooke
Conditions:
Covid19
Eligibility:
All Genders
Brief Summary
Although evidence from the management of other viral respiratory infections suggest that early multidisciplinary rehabilitation could mitigate the adverse effects of the severe form of the illness, an...
Eligibility Criteria
Inclusion
- Patients with medical clearance (physical deconditioning; hemodynamically stable; oxygen therapy by nasal cannula \< 4 L/min for saturation \> 92%; resting respiratory rate \< 24; and heart rate between 50 and 120 beats per minute). Controls were paired with those of the CORE program according to age, sex and pre-admission origin
Exclusion
- None
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 5 2022
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT04771052
Start Date
September 1 2020
End Date
January 5 2022
Last Update
May 23 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CIUSSS de l'Estrie-Centre hospitalier universitaire de Sherbrooke (CHUS)
Sherbrooke, Quebec, Canada, J1J 3H5
2
Centre hospitalier affilié universitaire régional (CHAUR)
Trois-Rivières, Quebec, Canada, G8Z 3R9